Lombard Odier Asset Management (Switzerland)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-530,452
| Closed | -$3.24M | – | 264 |
|
|
2023
Q1 | $3.24M | Buy |
530,452
+202,526
| +62% | +$1.24M | 0.28% | 84 |
|
|
2022
Q4 | $2.1M | Hold |
327,926
| – | – | 0.17% | 118 |
|
|
2022
Q3 | $3.14M | Sell |
327,926
-84,162
| -20% | -$806K | 0.27% | 88 |
|
|
2022
Q2 | $4.55M | Sell |
412,088
-174
| -0% | -$1.92K | 0.39% | 65 |
|
|
2022
Q1 | $6.86M | Sell |
412,262
-537,622
| -57% | -$8.95M | 0.54% | 54 |
|
|
2021
Q4 | $18.1M | Buy |
949,884
+80,344
| +9% | +$1.53M | 1.16% | 34 |
|
|
2021
Q3 | $21.4M | Buy |
869,540
+80,978
| +10% | +$2M | 1.33% | 34 |
|
|
2021
Q2 | $20.5M | Buy |
788,562
+546,666
| +226% | +$14.2M | 1.04% | 42 |
|
|
2021
Q1 | $7.66M | Buy |
+241,896
| New | +$7.66M | 0.51% | 65 |
|